Virginia Blalack
Internal Medicine · Gulfport, MSNPI 1295965614
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.8% of the total across 372 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 16.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,743 and has fallen 99.2% since, to $14 in 2025.
Across 372 payments — averaging $13.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$859
- GSK$589
- Amgen$577
- AstraZeneca$495
- Pfizer$427
- Astellas Pharma US Inc$357
- plus $2K from 23 others
What the payments were for
- Food & beverage$5,178100%
- Education$80%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 63 | $859 |
| GSK | 42 | $589 |
| Amgen | 45 | $577 |
| AstraZeneca | 30 | $495 |
| Pfizer | 39 | $427 |
| Astellas Pharma US Inc | 24 | $357 |
| AbbVie(2 entities) | 21 | $269 |
| Lilly USA, LLC | 14 | $228 |
| Novartis | 15 | $183 |
| Merck | 10 | $167 |
| Sanofi-aventis U.S. LLC | 10 | $153 |
| Amarin Pharma, Inc. | 9 | $153 |
| Boehringer Ingelheim | 8 | $123 |
| Johnson & Johnson(2 entities) | 7 | $108 |
| Esperion Therapeutics, Inc. | 6 | $83 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $74 |
| Abbott | 5 | $65 |
| Biohaven Pharmaceuticals, Inc. | 2 | $44 |
| Kowa Pharmaceuticals America, Inc. | 3 | $41 |
| GRT US Holding, Inc. | 2 | $33 |
| E.r. Squibb & Sons, L.L.C. | 2 | $29 |
| Teva Pharmaceuticals USA, Inc. | 2 | $23 |
| Dynavax Technologies Corporation | 1 | $21 |
| Sunovion Pharmaceuticals Inc. | 1 | $16 |
| Shire North American Group Inc | 1 | $15 |
| Silk Road Medical, Inc. | 1 | $14 |
| Currax Pharmaceuticals LLC | 1 | $14 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $13 |
| Dexcom, Inc. | 1 | $13 |
How this compares
$5,186 in reported general payments places this provider in the 85th percentile of 846 internal medicine providers in Mississippi.
Other internal medicine in Gulfport
- Mousa MaaloufGulfport$14K
- David LarosaGulfport$14K
- Phillip ComptonGulfport$10K
- Lynn LeatherwoodGulfport$10K
- Jay SegarraGulfport$9K
- Boyd BenefieldGulfport$7K
- Kelly WilkinsonJackson$79K
- Shanna PettieJackson$53K
- Gabriel HernandezJackson$41K
- Indira VeerisettyRidgeland$25K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.